Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Mepivacaine-d3 is intended for use as an internal standard for the quantification of mepivacaine by GC- or LC-MS. Mepivacaine is an inhibitor of voltage-gated sodium channels (Navs) and a local anesthetic.1 It inhibits depolarization-induced currents in ND7/23 cells expressing Nav1.8 channels when used at concentrations of 30 and 100 µM. Mepivacaine (2% w/v) reduces lameness in horses with naturally occurring forelimb lameness.2 Formulations containing mepivacaine have been used as local and regional anesthetics.
WARNING This product is not for human or veterinary use.
1. Block of sensory neuronal Na+ channels by the secreolytic ambroxol is associated with an interaction with local anesthetic binding sites. Eur. J. Pharmacol. 630(1-3), 19-28 (2010).
2. Comparison of 2% mepivacaine and a solution of 2% lidocaine/epinephrine administered for median and ulnar nerve blocks in horses with naturally occurring forelimb lameness. Vet. Surg. 51(2), 279-285 (2022).